Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-03-05 @ 4:54 PM
Study NCT ID:
NCT06677060
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2024-11-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2029-12-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12-17
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-05
First Submit QC Date:
None
Study First Post Date:
2024-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED